Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Scarsi

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Trends in Molecular Medicine|November 28, 2012
Targeting CD4+CD28- T cells by blocking CD28 co-stimulationPaolo Airò, Mirko Scarsi
The Journal of Rheumatology|August 3, 2011
Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritisMirko Scarsi, Tamara Ziglioli, Paolo Airo'
The Journal of Rheumatology|March 17, 2010
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical responseMirko Scarsi, Tamara Ziglioli, Paolo Airò
Autoimmunity|March 20, 2010
Type I interferons in systemic autoimmunitySilvano Sozzani, Daniela Bosisio, Mirko Scarsi, et al.
Rheumatology International|December 11, 2007
Onset and enhancement of systemic sclerosis after treatments for multiple sclerosisPaolo Airo', Mirko Scarsi, Mara Rossi, et al.
Rheumatology International|May 31, 2015
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximabSilvia Piantoni, Mirko Scarsi, Angela Tincani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et alPaolo Airò, Enrico Colombo, Silvia Piantoni, et al.
The Israel Medical Association Journal : IMAJ|August 23, 2007
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune diseaseAngela Tincani, Mirko Scarsi, Franco Franceschini, et al.
Clinical Rheumatology|January 27, 2016
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritisSilvia Piantoni, Enrico Colombo, Angela Tincani, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abataceptEnrico Colombo, Mirko Scarsi, Silvia Piantoni, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Trends in Molecular Medicine|November 28, 2012
Targeting CD4+CD28- T cells by blocking CD28 co-stimulationPaolo Airò, Mirko Scarsi
The Journal of Rheumatology|August 3, 2011
Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritisMirko Scarsi, Tamara Ziglioli, Paolo Airo'
The Journal of Rheumatology|March 17, 2010
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical responseMirko Scarsi, Tamara Ziglioli, Paolo Airò
Autoimmunity|March 20, 2010
Type I interferons in systemic autoimmunitySilvano Sozzani, Daniela Bosisio, Mirko Scarsi, et al.
Rheumatology International|December 11, 2007
Onset and enhancement of systemic sclerosis after treatments for multiple sclerosisPaolo Airo', Mirko Scarsi, Mara Rossi, et al.
Rheumatology International|May 31, 2015
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximabSilvia Piantoni, Mirko Scarsi, Angela Tincani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
CD8+ T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et alPaolo Airò, Enrico Colombo, Silvia Piantoni, et al.
The Israel Medical Association Journal : IMAJ|August 23, 2007
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune diseaseAngela Tincani, Mirko Scarsi, Franco Franceschini, et al.
Clinical Rheumatology|January 27, 2016
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritisSilvia Piantoni, Enrico Colombo, Angela Tincani, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abataceptEnrico Colombo, Mirko Scarsi, Silvia Piantoni, et al.
Pageof 4